CSL has received approval from the EC for Andembry (garadacimab) to prevent recu...
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (...
Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s firs...
New EU regulations aim to speed up health technology assessments (HTAs), but the...
Newleos has closed an oversubscribed Series A financing round, raising $93.5m to...
Health Canada has approved Novartis Canada’s Fabhalta (iptacopan capsules) as th...
In a groundbreaking study released in February 2025, researchers at the Institut...
The intricate mosaic of brain evolution continues to captivate scientists, espec...
In a recent breakthrough published in the National Science Review, researchers h...
Recent research has unveiled groundbreaking insights into the ultrafast melting ...
Cal Poly has recently recognized the outstanding contributions of its faculty wi...
In a groundbreaking study, researchers from the University of Chicago Pritzker S...
Icaritin, a potent prenylflavonoid isolated from the Epimedium genus, has surged...
In a groundbreaking study published in Physical Review Letters, researchers at t...
A groundbreaking study led by Professor CHU Yannan from the Hefei Institutes of ...
A team of innovative scientists from China has carved a niche in agricultural bi...
